Home
Home

RNAi

Alnylam announces proof-of-concept data from RNAi program

Alnylam announces proof-of-concept data from RNAi program
Yahoo/Fly on the Wall

The Medicines Co., Alnylam form strategic alliance to develop RNAi Therapeutics

The Medicines Co., Alnylam form strategic alliance to develop RNAi Therapeutics
Yahoo/Fly on the Wall

2 Biotech Stocks To Consider This Week In The Wake Of Trial Data

2 Biotech Stocks To Consider This Week In The Wake Of Trial Data
Seeking Alpha

Alnylam and Genzyme Form Alliance to Develop and Commercialize RNAi Therapeutics in Asia

Alnylam and Genzyme Form Alliance to Develop and Commercialize RNAi Therapeutics in Asia
Yahoo

Future Trends In RNAi Drug Delivery

Future Trends In RNAi Drug Delivery
Seeking Alpha

Good News For Alnylam: PBL Making Baulcombe Patent Widely Available

Good News For Alnylam: PBL Making Baulcombe Patent Widely Available
Seeking Alpha

Alnylam, Medtronic RNAi drug-device combo wows with preclinical data

Alnylam, Medtronic RNAi drug-device combo wows with preclinical data
Fierce Drug Delivery

A Step Forward for RNA Interference

A Step Forward for RNA Interference
NY Times, NY

Alnylam Presents Phase I Data for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers, at American Society of Clinical Oncology (ASCO) Meeting

Alnylam Presents Phase I Data for ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancers, at American Society of Clinical Oncology (ASCO) Meeting
Yahoo/BusinessWire

News

RNAi Is On Sale
Motley Fool